Stay updated on ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer
Sign up to get notified when there's something new on the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page.

Latest updates to the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check26 days agoChange DetectedThe page now displays a funding-related operating-status notice and a new software/document version (v3.2.0), replacing the previous v3.1.0.SummaryDifference2%

- Check33 days agoChange DetectedAdded a new version label (v3.1.0) and removed several drug-safety/quality topics and an older version label (v3.0.2). Overall, this signals a version update with a cleanup of older safety-topic content.SummaryDifference0.2%

- Check47 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.1%

- Check54 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.1%

- Check62 days agoChange DetectedThe webpage has undergone significant updates, including the addition of new facility names and locations, as well as the introduction of various medical topics and resources related to cancer treatment. Notably, the previous version's references to certain genetic resources and specific locations have been removed.SummaryDifference19%

- Check76 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.SummaryDifference0.0%

Stay in the know with updates to ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer
Enter your email address, and we'll notify you when there's something new on the ATHENA Clinical Trial: Rucaparib+Nivolumab in Ovarian Cancer page.